The global Seasonal Influenza Vaccines Therapeutics Market is expected to reach USD 43.39 Biliion by the end of 2032, with a valuation of USD 25.04 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 6.3%. The study examines the factors driving and limiting the global Seasonal...